Sequenom
Signal active
Organization
Contact Information
Overview
Sequenom offers genetic analysis products and diagnostic tests for non-invasive prenatal genetic disorders. The company provides a nucleic acid analysis platform that measures genetic target material and variations.
About
Industries
Biotechnology, Health Care, Genetics, Health Diagnostics
Founded
1994
Employees
501-1000
Headquarters locations
San Diego, California, United States, North America
Social
Profile Resume
Sequenom headquartered in United States, North America, operates in the Biotechnology, Health Care, Genetics, Health Diagnostics sector. The company focuses on Biotechnology and has secured $11.9B in funding across 64 round(s). With a team of 501-1000 employees, Sequenom is actively contributing to advancements in Biotechnology. Their latest funding round, Post-IPO Debt - Sequenom, raised $130.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
4
Investors
0
Lead Investors
0
Total Funding Amount
$185.3M
Details
0
Sequenom has raised a total of $185.3M in funding over 0 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|
Investors
Sequenom is funded by 2 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Sequenom | - | FUNDING ROUND - Sequenom | 2.2M |
| National Institutes of Health | - | FUNDING ROUND - National Institutes of Health | 2.2M |
Recent Activity
Funding Round
Sep 24, 2012
Sequenom raised $130000000 on 2012-09-24 in Post-IPO Debt
Funding Round
May 21, 2010
Sequenom raised $51605250 on 2010-05-21 in Post-IPO Equity
Funding Round
Dec 29, 2009
Sequenom raised $1512015 on 2009-12-29 in Post-IPO Equity
Funding Round
Nov 08, 2001
Sequenom raised $2200000 on 2001-11-08 in Grant